We have developed and thoroughly validated a solid-phase sandwich enzyme-linked immunosorbent assay (EUSA) on microtiter platesfor osteocalan in human serum with use of an antibody raised against human osteocalcin. We used a monoclonal antibody against bovine osteocalcin as the capture antibody; the second antibody was a potyclonal antibody against human osteocalcin. The amount of bound second antibody was determined with use of swine antirabbit anthody labeled with horseradish peroxidase.We demonstrated independence of volume and determined the recovery of added standard and within-and between-assay precision. The minimal detection limit for osteocalcin was between 1.0 and 1.5 pg/L and the midpoint of the standard curve ranged from 14 to 17 tg/L The intraassay CV was 8% in the range 2.7-52 1ig/L the interassay CV was usually 15% in the same range. Analytical recovery of human osteocalcin standard added to serum samples was consistently >90%. Values for osteocalcin measured in serum from 44 normal subjects were similar to those obtained with a competitive enzyme immunoassay (EIA) that used a monodonal antibody against bovine osteocalcin. There was a good correlation between the two assays 
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MaterIals and Methods Subjects
The 44 women studied, ages 49-54 years, were in good health and were taking no drugs known to affect bone metabolism. 
. Although this is the absorptivity for bovine osteocalcun, we used it to quantify human osteocalcin because there is 90% sequence homology between the two proteins (which differ from each other by only five amino acids). This absorptivity was also recently used by Bouillon et al. (27) to quantify purified human osteocalcun. Osteocalcin stock standards were freeze-dried and stored in 4-, 20-, and 100-zg aliquots. Working standard solutions (1.6-100 p.gfL) were stored at -70#{176}C in 0.5-mL aliquots and were used within 1 week of thawing.
Osteocalcin peptides. Osteocalcin immunoassay. antibody R-188 and polyclonal antibody R-187, also raised against human osteocalcin. All three antisera detected a major immunoreactive peak with an elution volume corresponding to the molecular mass of osteocalcin (Mr 6000) (Figure 3) 
